efectos secundarios del glp 1 Fármacos basados en GLP-1: mecanismos implicados en el tratamiento de la obesidad La revolución de los fármacos
Description
They propose based on rodent and monkey studies that this kind of molecule, when administered at high enough doses, may result in weight loss comparable to the weight loss seen with drugs that include GLP-1 as a target, and without the tolerability issues like nausea and vomiting that often come with the approved treatments, according to a peer-reviewed draft paper published this week
[DOI] [PMC free article] [PubMed] [Google Scholar] Masaki T., Ozeki Y., Yoshida Y., Okamoto M., Miyamoto S., Gotoh K., Shibata H
Insurance Not typically covered
These medicines mimic a natural gut hormone, stimulating insulin release only when blood sugar is elevated, which reduces the risk of dangerously low glucose levels
Temporary nausea, constipation, or mild digestive issues are common early on but usually improve with time
Drug pricing in the United States is not transparent, and many entities get a share of the dollars that the health plans have budgeted
